Search hospitals > North Carolina > Wilmington

PMG Research of Wilmington, LLC

Claim this profile
Wilmington, North Carolina 28401
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Arthritis
Conducts research for Rheumatoid Arthritis
Conducts research for Juvenile Idiopathic Arthritis
162 reported clinical trials
3 medical researchers
Photo of PMG Research of Wilmington, LLC in WilmingtonPhoto of PMG Research of Wilmington, LLC in WilmingtonPhoto of PMG Research of Wilmington, LLC in Wilmington

Summary

PMG Research of Wilmington, LLC is a medical facility located in Wilmington, North Carolina. This center is recognized for care of Diabetes, Type 2 Diabetes, Arthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis and other specialties. PMG Research of Wilmington, LLC is involved with conducting 162 clinical trials across 158 conditions. There are 3 research doctors associated with this hospital, such as John Charles Parker, Brian Webster, and James Appel.

Top PIs

Clinical Trials running at PMG Research of Wilmington, LLC

Female
Endometriosis
Image of trial facility.

Elagolix + COC

for Endometriosis

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental health. This study will evaluate how well elagolix in combination with combined oral contraceptives (COC) works within the body and/or how safe it is compared to placebo (does not contain treatment drug). This study will assess the dysmenorrhea (painful periods) response in participants with endometriosis and associated pain. Elagolix is an approved drug for the management of moderate to severe pain associated with endometriosis. Participants are randomly put in 1 of 3 groups, called treatment arms. Each group receives a different treatment. There is a 1 in 3 chance that participants will be assigned to placebo. Adult female participants who still have periods with a diagnosis of endometriosis will be enrolled. Around 800 participants will be enrolled in the study at multiple sites in the United States, including Puerto Rico. Participants will receive oral elagolix or placebo tablets in combination with combined oral contraceptive (COC) or placebo capsules for 3 months. All the participants will receive elagolix tablets in combination with COC tablets from Month 4 through Month 18. There will be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 37 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at PMG Research of Wilmington, LLC?
PMG Research of Wilmington, LLC is a medical facility located in Wilmington, North Carolina. This center is recognized for care of Diabetes, Type 2 Diabetes, Arthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis and other specialties. PMG Research of Wilmington, LLC is involved with conducting 162 clinical trials across 158 conditions. There are 3 research doctors associated with this hospital, such as John Charles Parker, Brian Webster, and James Appel.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security